T&R Biofab Co., Ltd. (KOSDAQ:246710)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,265.00
+10.00 (0.31%)
At close: Mar 13, 2026
Market Cap155.31B +82.7%
Revenue (ttm)20.67B +297.7%
Net Income-9.61B
EPS-371.66
Shares Out47.57M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume457,746
Average Volume723,492
Open3,160.00
Previous Close3,255.00
Day's Range3,110.00 - 3,365.00
52-Week Range1,127.00 - 4,925.00
Beta0.49
RSI51.00
Earnings DateMar 17, 2026

About T&R Biofab

T&R Biofab Co., Ltd. develops and commercializes various regenerative medical technologies. It offers 3D-printed medical devices; and bio-surgical solutions, which includes wound dressing and acellular dermal matrix, as well as biomaterials and biopharmaceuticals. The company was founded in 2013 and is based in Siheung-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 246710
Full Company Profile

Financial Performance

Financial Statements